Global Rx to OTC Switches Market Size, Status and Forecast 2020-2026

August 2020 | 97 pages | ID: GE3CFA0A1C99EN
QYResearch

Abstracts

This report focuses on the global Rx to OTC Switches status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Rx to OTC Switches development in North America, Europe and Asia-Pacific, Southeast Asia, India and Central & South America.
The key players covered in this study

• Bayer
• C. H. Boehringer Sohn
• GlaxoSmithKline
• Johnson & Johnson
• Merck
• Novartis
• Pfizer
• Sanofi

Market segment by Type, the product can be split into

• Analgesics
• Anti-infectives
• Gastrointestinal Drugs
• Others

Market segment by Application, split into

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Market segment by Regions/Countries, this report covers

• North America
• Europe
• Asia-Pacific
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Rx to OTC Switches status, future forecast, growth opportunity, key market and key players.
• To present the Rx to OTC Switches development in North America, Europe and Asia-Pacific, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Rx to OTC Switches are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Rx to OTC Switches Revenue
1.4 Market Analysis by Type
  1.4.1 Global Rx to OTC Switches Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Analgesics
  1.4.3 Anti-infectives
  1.4.4 Gastrointestinal Drugs
  1.4.5 Others
1.5 Market by Application
  1.5.1 Global Rx to OTC Switches Market Share by Application: 2020 VS 2026
  1.5.2 Hospital Pharmacies
  1.5.3 Retail Pharmacies
  1.5.4 Online Pharmacies
1.6 Coronavirus Disease 2019 (Covid-19): Rx to OTC Switches Industry Impact
  1.6.1 How the Covid-19 is Affecting the Rx to OTC Switches Industry
    1.6.1.1 Rx to OTC Switches Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Rx to OTC Switches Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Rx to OTC Switches Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Rx to OTC Switches Market Perspective (2015-2026)
2.2 Rx to OTC Switches Growth Trends by Regions
  2.2.1 Rx to OTC Switches Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Rx to OTC Switches Historic Market Share by Regions (2015-2020)
  2.2.3 Rx to OTC Switches Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Rx to OTC Switches Market Growth Strategy
  2.3.6 Primary Interviews with Key Rx to OTC Switches Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Rx to OTC Switches Players by Market Size
  3.1.1 Global Top Rx to OTC Switches Players by Revenue (2015-2020)
  3.1.2 Global Rx to OTC Switches Revenue Market Share by Players (2015-2020)
  3.1.3 Global Rx to OTC Switches Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Rx to OTC Switches Market Concentration Ratio
  3.2.1 Global Rx to OTC Switches Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Rx to OTC Switches Revenue in 2019
3.3 Rx to OTC Switches Key Players Head office and Area Served
3.4 Key Players Rx to OTC Switches Product Solution and Service
3.5 Date of Enter into Rx to OTC Switches Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Rx to OTC Switches Historic Market Size by Type (2015-2020)
4.2 Global Rx to OTC Switches Forecasted Market Size by Type (2021-2026)

5 RX TO OTC SWITCHES BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Rx to OTC Switches Market Size by Application (2015-2020)
5.2 Global Rx to OTC Switches Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Rx to OTC Switches Market Size (2015-2020)
6.2 Rx to OTC Switches Key Players in North America (2019-2020)
6.3 North America Rx to OTC Switches Market Size by Type (2015-2020)
6.4 North America Rx to OTC Switches Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Rx to OTC Switches Market Size (2015-2020)
7.2 Rx to OTC Switches Key Players in Europe (2019-2020)
7.3 Europe Rx to OTC Switches Market Size by Type (2015-2020)
7.4 Europe Rx to OTC Switches Market Size by Application (2015-2020)

8 ASIA-PACIFIC

8.1 Asia-Pacific Rx to OTC Switches Market Size (2015-2020)
8.2 Rx to OTC Switches Key Players in Asia-Pacific (2019-2020)
8.3 Asia-Pacific Rx to OTC Switches Market Size by Type (2015-2020)
8.4 Asia-Pacific Rx to OTC Switches Market Size by Application (2015-2020)
(2015-2020)
(2015-2020)

9 SOUTHEAST ASIA

9.1 Southeast Asia Rx to OTC Switches Market Size (2015-2020)
9.2 Rx to OTC Switches Key Players in Southeast Asia (2019-2020)
9.3 Southeast Asia Rx to OTC Switches Market Size by Type (2015-2020)
9.4 Southeast Asia Rx to OTC Switches Market Size by Application (2015-2020)

10 INDIA

10.1 India Rx to OTC Switches Market Size (2015-2020)
10.2 Rx to OTC Switches Key Players in India (2019-2020)
10.3 India Rx to OTC Switches Market Size by Type (2015-2020)
10.4 India Rx to OTC Switches Market Size by Application (2015-2020)

11 CENTRAL & SOUTH AMERICA

11.1 Central & South America Rx to OTC Switches Market Size (2015-2020)
11.2 Rx to OTC Switches Key Players in Central & South America (2019-2020)
11.3 Central & South America Rx to OTC Switches Market Size by Type (2015-2020)
11.4 Central & South America Rx to OTC Switches Market Size by Application (2015-2020)

12 KEY PLAYERS PROFILES

12.1 Bayer
  12.1.1 Bayer Company Details
  12.1.2 Bayer Business Overview and Its Total Revenue
  12.1.3 Bayer Rx to OTC Switches Introduction
  12.1.4 Bayer Revenue in Rx to OTC Switches Business (2015-2020))
  12.1.5 Bayer Recent Development
12.2 C. H. Boehringer Sohn
  12.2.1 C. H. Boehringer Sohn Company Details
  12.2.2 C. H. Boehringer Sohn Business Overview and Its Total Revenue
  12.2.3 C. H. Boehringer Sohn Rx to OTC Switches Introduction
  12.2.4 C. H. Boehringer Sohn Revenue in Rx to OTC Switches Business (2015-2020)
  12.2.5 C. H. Boehringer Sohn Recent Development
12.3 GlaxoSmithKline
  12.3.1 GlaxoSmithKline Company Details
  12.3.2 GlaxoSmithKline Business Overview and Its Total Revenue
  12.3.3 GlaxoSmithKline Rx to OTC Switches Introduction
  12.3.4 GlaxoSmithKline Revenue in Rx to OTC Switches Business (2015-2020)
  12.3.5 GlaxoSmithKline Recent Development
12.4 Johnson & Johnson
  12.4.1 Johnson & Johnson Company Details
  12.4.2 Johnson & Johnson Business Overview and Its Total Revenue
  12.4.3 Johnson & Johnson Rx to OTC Switches Introduction
  12.4.4 Johnson & Johnson Revenue in Rx to OTC Switches Business (2015-2020)
  12.4.5 Johnson & Johnson Recent Development
12.5 Merck
  12.5.1 Merck Company Details
  12.5.2 Merck Business Overview and Its Total Revenue
  12.5.3 Merck Rx to OTC Switches Introduction
  12.5.4 Merck Revenue in Rx to OTC Switches Business (2015-2020)
  12.5.5 Merck Recent Development
12.6 Novartis
  12.6.1 Novartis Company Details
  12.6.2 Novartis Business Overview and Its Total Revenue
  12.6.3 Novartis Rx to OTC Switches Introduction
  12.6.4 Novartis Revenue in Rx to OTC Switches Business (2015-2020)
  12.6.5 Novartis Recent Development
12.7 Pfizer
  12.7.1 Pfizer Company Details
  12.7.2 Pfizer Business Overview and Its Total Revenue
  12.7.3 Pfizer Rx to OTC Switches Introduction
  12.7.4 Pfizer Revenue in Rx to OTC Switches Business (2015-2020)
  12.7.5 Pfizer Recent Development
12.8 Sanofi
  12.8.1 Sanofi Company Details
  12.8.2 Sanofi Business Overview and Its Total Revenue
  12.8.3 Sanofi Rx to OTC Switches Introduction
  12.8.4 Sanofi Revenue in Rx to OTC Switches Business (2015-2020)
  12.8.5 Sanofi Recent Development

13 ANALYST'S VIEWPOINTS/CONCLUSIONS

14 APPENDIX

14.1 Research Methodology
  14.1.1 Methodology/Research Approach
  14.1.2 Data Source
14.2 Disclaimer
14.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Rx to OTC Switches Key Market Segments
Table 2. Key Players Covered: Ranking by Rx to OTC Switches Revenue
Table 3. Ranking of Global Top Rx to OTC Switches Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Rx to OTC Switches Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Analgesics
Table 6. Key Players of Anti-infectives
Table 7. Key Players of Gastrointestinal Drugs
Table 8. Key Players of Others
Table 9. COVID-19 Impact Global Market: (Four Rx to OTC Switches Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Rx to OTC Switches Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Rx to OTC Switches Players to Combat Covid-19 Impact
Table 14. Global Rx to OTC Switches Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Rx to OTC Switches Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Rx to OTC Switches Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Rx to OTC Switches Market Share by Regions (2015-2020)
Table 18. Global Rx to OTC Switches Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Rx to OTC Switches Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Rx to OTC Switches Market Growth Strategy
Table 24. Main Points Interviewed from Key Rx to OTC Switches Players
Table 25. Global Rx to OTC Switches Revenue by Players (2015-2020) (Million US$)
Table 26. Global Rx to OTC Switches Market Share by Players (2015-2020)
Table 27. Global Top Rx to OTC Switches Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rx to OTC Switches as of 2019)
Table 28. Global Rx to OTC Switches by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Rx to OTC Switches Product Solution and Service
Table 31. Date of Enter into Rx to OTC Switches Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Rx to OTC Switches Market Size by Type (2015-2020) (Million US$)
Table 34. Global Rx to OTC Switches Market Size Share by Type (2015-2020)
Table 35. Global Rx to OTC Switches Revenue Market Share by Type (2021-2026)
Table 36. Global Rx to OTC Switches Market Size Share by Application (2015-2020)
Table 37. Global Rx to OTC Switches Market Size by Application (2015-2020) (Million US$)
Table 38. Global Rx to OTC Switches Market Size Share by Application (2021-2026)
Table 39. North America Key Players Rx to OTC Switches Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Rx to OTC Switches Market Share (2019-2020)
Table 41. North America Rx to OTC Switches Market Size by Type (2015-2020) (Million US$)
Table 42. North America Rx to OTC Switches Market Share by Type (2015-2020)
Table 43. North America Rx to OTC Switches Market Size by Application (2015-2020) (Million US$)
Table 44. North America Rx to OTC Switches Market Share by Application (2015-2020)
Table 45. Europe Key Players Rx to OTC Switches Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Rx to OTC Switches Market Share (2019-2020)
Table 47. Europe Rx to OTC Switches Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Rx to OTC Switches Market Share by Type (2015-2020)
Table 49. Europe Rx to OTC Switches Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Rx to OTC Switches Market Share by Application (2015-2020)
Table 51. Asia-Pacific Key Players Rx to OTC Switches Revenue (2019-2020) (Million US$)
Table 52. Asia-Pacific Key Players Rx to OTC Switches Market Share (2019-2020)
Table 53. Asia-Pacific Rx to OTC Switches Market Size by Type (2015-2020) (Million US$)
Table 54. Asia-Pacific Rx to OTC Switches Market Share by Type (2015-2020)
Table 55. Asia-Pacific Rx to OTC Switches Market Size by Application (2015-2020) (Million US$)
Table 56. Asia-Pacific Rx to OTC Switches Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Rx to OTC Switches Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Rx to OTC Switches Market Share (2019-2020)
Table 59. Southeast Asia Rx to OTC Switches Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Rx to OTC Switches Market Share by Type (2015-2020)
Table 61. Southeast Asia Rx to OTC Switches Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Rx to OTC Switches Market Share by Application (2015-2020)
Table 63. India Key Players Rx to OTC Switches Revenue (2019-2020) (Million US$)
Table 64. India Key Players Rx to OTC Switches Market Share (2019-2020)
Table 65. India Rx to OTC Switches Market Size by Type (2015-2020) (Million US$)
Table 66. India Rx to OTC Switches Market Share by Type (2015-2020)
Table 67. India Rx to OTC Switches Market Size by Application (2015-2020) (Million US$)
Table 68. India Rx to OTC Switches Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Rx to OTC Switches Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Rx to OTC Switches Market Share (2019-2020)
Table 71. Central & South America Rx to OTC Switches Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Rx to OTC Switches Market Share by Type (2015-2020)
Table 73. Central & South America Rx to OTC Switches Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Rx to OTC Switches Market Share by Application (2015-2020)
Table 75. Bayer Company Details
Table 76. Bayer Business Overview
Table 77. Bayer Product
Table 78. Bayer Revenue in Rx to OTC Switches Business (2015-2020) (Million US$)
Table 79. Bayer Recent Development
Table 80. C. H. Boehringer Sohn Company Details
Table 81. C. H. Boehringer Sohn Business Overview
Table 82. C. H. Boehringer Sohn Product
Table 83. C. H. Boehringer Sohn Revenue in Rx to OTC Switches Business (2015-2020) (Million US$)
Table 84. C. H. Boehringer Sohn Recent Development
Table 85. GlaxoSmithKline Company Details
Table 86. GlaxoSmithKline Business Overview
Table 87. GlaxoSmithKline Product
Table 88. GlaxoSmithKline Revenue in Rx to OTC Switches Business (2015-2020) (Million US$)
Table 89. GlaxoSmithKline Recent Development
Table 90. Johnson & Johnson Company Details
Table 91. Johnson & Johnson Business Overview
Table 92. Johnson & Johnson Product
Table 93. Johnson & Johnson Revenue in Rx to OTC Switches Business (2015-2020) (Million US$)
Table 94. Johnson & Johnson Recent Development
Table 95. Merck Company Details
Table 96. Merck Business Overview
Table 97. Merck Product
Table 98. Merck Revenue in Rx to OTC Switches Business (2015-2020) (Million US$)
Table 99. Merck Recent Development
Table 100. Novartis Company Details
Table 101. Novartis Business Overview
Table 102. Novartis Product
Table 103. Novartis Revenue in Rx to OTC Switches Business (2015-2020) (Million US$)
Table 104. Novartis Recent Development
Table 105. Pfizer Company Details
Table 106. Pfizer Business Overview
Table 107. Pfizer Product
Table 108. Pfizer Revenue in Rx to OTC Switches Business (2015-2020) (Million US$)
Table 109. Pfizer Recent Development
Table 110. Sanofi Business Overview
Table 111. Sanofi Product
Table 112. Sanofi Company Details
Table 113. Sanofi Revenue in Rx to OTC Switches Business (2015-2020) (Million US$)
Table 114. Sanofi Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Rx to OTC Switches Market Share by Type: 2020 VS 2026
Figure 2. Analgesics Features
Figure 3. Anti-infectives Features
Figure 4. Gastrointestinal Drugs Features
Figure 5. Others Features
Figure 6. Global Rx to OTC Switches Market Share by Application: 2020 VS 2026
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Rx to OTC Switches Report Years Considered
Figure 11. Global Rx to OTC Switches Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Rx to OTC Switches Market Share by Regions: 2020 VS 2026
Figure 13. Global Rx to OTC Switches Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Rx to OTC Switches Market Share by Players in 2019
Figure 16. Global Top Rx to OTC Switches Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rx to OTC Switches as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Rx to OTC Switches Revenue in 2019
Figure 18. North America Rx to OTC Switches Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Rx to OTC Switches Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Asia-Pacific Rx to OTC Switches Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Rx to OTC Switches Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Rx to OTC Switches Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Rx to OTC Switches Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Bayer Revenue Growth Rate in Rx to OTC Switches Business (2015-2020)
Figure 26. C. H. Boehringer Sohn Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. C. H. Boehringer Sohn Revenue Growth Rate in Rx to OTC Switches Business (2015-2020)
Figure 28. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. GlaxoSmithKline Revenue Growth Rate in Rx to OTC Switches Business (2015-2020)
Figure 30. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Johnson & Johnson Revenue Growth Rate in Rx to OTC Switches Business (2015-2020)
Figure 32. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Merck Revenue Growth Rate in Rx to OTC Switches Business (2015-2020)
Figure 34. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Novartis Revenue Growth Rate in Rx to OTC Switches Business (2015-2020)
Figure 36. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Pfizer Revenue Growth Rate in Rx to OTC Switches Business (2015-2020)
Figure 38. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Sanofi Revenue Growth Rate in Rx to OTC Switches Business (2015-2020)
Figure 40. Bottom-up and Top-down Approaches for This Report
Figure 41. Data Triangulation
Figure 42. Key Executives Interviewed